Medindia

X

Endologix Reports 28% Fourth Quarter 2009 Revenue Growth and Continued Positive Cash Flow from Operations

Friday, February 19, 2010 Corporate News J E 4
Advertisement
Provides 2010 revenue guidance of $62 to $66 million, an increase of 18% to 26%

COMPANY CONTACT:

INVESTOR CONTACTS:

Endologix, Inc.

The Ruth Group

John McDermott, CEO

Nick Laudico (646) 536-7030

(949) 595-7200

Zack Kubow (646) 536-7020

www.endologix.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
FDA CONSUMER HEALTH INFORMATION - Don't Get Burned...
S
Pittsburgh Neurosurgeons Explore Use of Drug that ...